Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine Maintenance in AML
NCT00398983Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2006
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in acute myeloid leukemia (AML), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2006; status: completed.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00398983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398983.